NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • #TrumpTrade
  • 24-HOUR Pass →
  • Invest ↗
Sign in Subscribe

Nucor and Steel Dynamics Warn of Weaker Q4 Earnings

Nucor and Steel Dynamics expect fourth-quarter earnings to miss Wall Street estimates due to seasonal demand, lower steel prices, and maintenance outages.

Nucor and Steel Dynamics Warn of Weaker Q4 Earnings
Credit: Bloomberg
Already have an account? Sign in.
12/17/2025 · 9:29 AM
NUE
/ Don't stop with just one post.

Related↓

Hot Steel
09/18/2025 · 6:06 AM

Nucor Slashes Profit Expectations: What You Need to Know

Nucor cut its quarterly profit forecast to $2.05-$2.15/share, down from $2.60. All segments face lower volumes, margins, or higher costs.

/ Subscriber only
/ Read more

Feed↓

Tilray Brands Reports Narrower Q2 Loss Despite Mixed Sales Performance
01/08/2026 · 4:51 PM

Tilray Brands Reports Narrower Q2 Loss Despite Mixed Sales Performance

Tilray (TLRY) narrows Q2 losses to $43.5M with 3% revenue growth driven by cannabis gains, though beverage sales decline 21% amid international expansion strategy.

/ Subscriber only
GM Takes $6 Billion EV Writedown as Electric Vehicle Market Cools
01/08/2026 · 4:29 PM

GM Takes $6 Billion EV Writedown as Electric Vehicle Market Cools

General Motors (GM) announces $6 billion in EV-related charges as demand weakens and Trump eliminates tax credits, joining Ford in massive electric vehicle pullback.

/ Subscriber only
Merck Eyes $19B Cancer Drugmaker Revolution Medicines in Major Biotech Deal
Featured/ 01/08/2026 · 3:59 PM

Merck Eyes $28-32 Billion Deal for Cancer Drugmaker Revolution Medicines

Merck negotiates potential acquisition of Revolution Medicines for up to $32B, seeking new cancer treatments as Keytruda patent expiration looms in 2028.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe